Blog

• 
• 
• 
• 

Phaeodactylum tricornutum is a microscopic, single-celled algae with outsized potential.

A new device that can image diseases of the retina more quickly will soon be tested during ophthalmic surgeries with Vanderbilt Eye Institute collaborators.

The prototype was designed by a Vanderbilt engineering undergraduate, who is first author on a paper about the work she will present today at the largest photonics conference in the world.

Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes.

If you’ve kept up with science-related news lately, then you’ve probably heard about CRISPR-Cas9, the latest and greatest new tool for gene editing.

Clostridium difficile (C. difficile) infection is the leading cause of hospital-acquired diarrhea, causing nearly a half million infections in the United States each year. Recurrence after treatment with antibiotics is common and new therapies are needed.

A six-member group of biomedical scientists from Europe and the United States, including Eric Delpire, PhD, MS, professor of Anesthesiology, has been awarded a $6 million grant to study the role of dietary potassium in hypertension.

The five-year grant was awarded by the Paris-based Fondation LeDucq as part of its Transatlantic Networks of Excellence Program.

The U.S. Defense Advanced Research Projects Agency (DARPA) has signed a five-year cooperative agreement worth up to $28 million with Vanderbilt University Medical Center (VUMC) to develop methods for preventing the global spread of viruses like chikungunya and Zika.

Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.

A new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators found that low-income residents in those socioeconomically disadvantaged neighborhoods died much earlier than the average American.

The next installment of the Vanderbilt University School of Medicine’s Enabling Innovations Initiative (eI2) speaker series is set for Friday, February 2nd at 3PM in Light Hall 214.  eI2 is SOM’s new program to promote a culture of innovations and dissemination of new knowledge and discovery through entrepreneurial pathways.  The February 2nd Seminar will feature Dr.

Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram Cancer Center (VICC) have announced a new collaboration to improve outcomes for cancer patients.

As part of the initial research project, Tempus will use its Tempus O platform to collect and structure clinical data from the cancer center’s electronic health record. Tempus also will provide next generation sequencing and analysis for a subset of patients in order to identify actionable gene alterations.